Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ishii A et al. – The findings indicate that S100A6 may be associated with the stepwise progression and/or invasion of lung adenocarcinoma, especially BAC–type adenocarcinoma. The present results suggest the utility of S100A6 immunohistochemistry as a marker for estimation of malignancy in adenocarcinoma with a BAC component.

Related Articles

Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
Lung Cancer, 11/06/09    Relevance Score: 67%

Fatal gemcitabine-induced pulmonary toxicity in metastatic gallbladder adenocarcinoma
Cancer Chemotherapy and Pharmacology, 11/18/09    Relevance Score: 66%

Risk Factors for Anastomotic Leakage Following Intersphincteric Resection for Very Low Rectal Adenocarcinoma
Journal of Gastrointestinal Surgery, 10/23/09    Relevance Score: 65%

Expression of dual-specificity tyrosine-(gamma)-phosphorylation–regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma
The Journal of Thoracic and Cardiovascular Surgery, 10/13/09    Relevance Score: 65%

Hypertrophic Pulmonary Osteoarthropathy Diagnosed by FDG PET-CT in a Patient With Lung Adenocarcinoma
Clinical Nuclear Medicine, 10/07/09    Relevance Score: 64%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address